Prognostic value of the neutrophil-lymphocyte ratio and CA 19-9 in predicting survival inpatients with metastatic pancreatic cancer

Dede, I.Cetin, M.Cetin, S.2024-09-182024-09-1820180923-75341569-8041https://hdl.handle.net/20.500.12483/1295743rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessPrognostic value of the neutrophil-lymphocyte ratio and CA 19-9 in predicting survival inpatients with metastatic pancreatic cancerConference Object29256256WOS:000459277301329Q1